Cargando…
组蛋白去乙酰化酶抑制剂联合免疫检查点抑制剂治疗肿瘤的研究进展
Immunotherapy is one of the main strategies of anti-tumor therapy at present, in which immune checkpoint inhibitors (ICIs) are the most widely used drug. ICIs resistance is mediated by a variety of cytokines and immune cells, and the mechanism is complex, which is the main reason for the failure of...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
中国肺癌杂志编辑部
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143971/ https://www.ncbi.nlm.nih.gov/pubmed/33819971 http://dx.doi.org/10.3779/j.issn.1009-3419.2021.102.11 |
Ejemplares similares
-
组蛋白去乙酰化酶抑制剂Belinostat对髓源性树突状细胞免疫功能的作用研究
Publicado: (2018) -
肺癌免疫检查点抑制剂的联合治疗研究进展
Publicado: (2020) -
免疫检查点抑制剂相关感染诊治建议
Publicado: (2019) -
免疫检查点抑制剂相关心肌炎的研究进展
Publicado: (2021) -
晚期肺神经内分泌肿瘤免疫检查点抑制剂治疗进展
Publicado: (2021)